Breaking News

ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
WORLD PATIENT SAFETY DAY 2024 | Get It Right, Make It Safe!
REGULATORY APPROVAL | PiaSky Becomes the First Monthly Treatment for PNH in the EU
ACCESS TO INNOVATION | UK Greenlights Gene-Editing Therapy Casgevy for β-Thalassaemia Treatment
GLOBAL SURVEY | Understanding the Thalassaemia Community Health Literacy & Its Impact on Care
Understanding the Thalassaemia Community Health Literacy and Its Impact on Care
JUST LISTEN | Voices of PK Deficiency Episode on the Impact of New International Standards
NEW APPROVAL | FDA Endorses Piasky for Paroxysmal Nocturnal Hemoglobinuria
CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study
SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024

English

Menu

Home
Who we are
What we do
Haemoglobin Disorders
Positions & Policies
Publications
Media Centre
- News
- Newsletters
- Events
- Videos
Contact us

Search for

Home/Education/JO’S STORY | Stand with Jo

JO’S STORY | Stand with Jo

Less than a minute

Thank you for your support!

09-Older-Child-Jo-Confused

Back to Jo’s story

Less than a minute

Facebook X LinkedIn Share via Email Print

Check Also

Scientific Literature

Luspatercept for the Treatment of Anaemia in Non-Transfusion-Dependent β-Thalassaemia (BEYOND): A Phase 2, Randomised, Double-blind, Multicentre, Placebo-controlled Trial
August 22, 2022

Quick links

For Patients
For Healthcare Professionals
For Associations
For Supporters
TIF Members
Useful Links
Sitemap

Follow us

Facebook
X
LinkedIn
YouTube
Instagram
RSS

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Facebook X WhatsApp

Back to top button

Close

Facebook
X
LinkedIn
YouTube
Instagram
RSS

Search for: